NeuroDevNet-supported researchers have made two groundbreaking discoveries that could lead to a less expensive and faster screening tool to identify young children, and even infants, with fetal alcohol spectrum disorder (FASD), and other neurological and psychiatric disorders such as attention deficit hyperactivity disorder, Parkinson’s disease and autism. In a global first, the Queen’s University team showed that children exposed to alcohol before birth have less control over their eye movements than typically developing children. They then collaborated on the development of analysis tools that allow an eye-tracking system made by Canada’s SR Research Ltd. to be used as a high-performance, low-cost screening tool. Hundreds of children from across Canada have already participated in these studies, and new research is examining if the same approaches can be used in infants as young as 12 months. Early detection and intervention can significantly improve a child’s quality of life and reduce health care costs.